Funding

Forlong Biotechnology

China · Biotech · Healthtech

Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer

Visit forlongbiotech.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-Series B$17.5MChangshu Guofa Venture — Role not disclosedFudan Capital — Role not disclosedKunsheng Relay Fund — Role not disclosed

Investors

Changshu Guofa VenturePre-Series BFudan CapitalPre-Series BKunsheng Relay FundPre-Series B

Coverage

May 19, 2026Forlong Biotechnology · Pre-Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesforlongbiotech.com ↗